According to Dr. Geetika Jassal, Medical Spokesperson, Cryoviva Life Sciences,“Regenerative medicine is advancing research into how cells and their biological signals may support tissue repair, including bone regeneration. Mesenchymal stem cells and their derivatives are being investigated for their potential role in bone formation, although their use in osteoporosis remains investigational. Stem cell banking involves collecting and preserving biological material, with quality and viability being important considerations for potential clinical use. Cord blood has established applications in transplantation for certain blood, immune and inherited metabolic disorders. However, banking cord blood does not guarantee access to future osteoporosis treatments, as different cell types have distinct therapeutic applications. Responsible counselling must bridge scientific progress with a clear understanding of current evidence, established clinical applications and limitations”